United Therapeutics Corp. (UTHR)
487.25
-8.94
(-1.80%)
USD |
NASDAQ |
Dec 31, 16:00
486.98
-0.27
(-0.06%)
After-Hours: 20:00
United Therapeutics Free Cash Flow: 1.116B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Gilead Sciences, Inc. | 9.162B |
| Insmed, Inc. | -906.14M |
| Johnson & Johnson | 20.46B |
| Catalyst Pharmaceuticals, Inc. | 234.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 562.10M |
| Cash from Investing (Quarterly) | 140.90M |
| Cash from Financing (Quarterly) | -956.00M |
| Free Cash Flow Per Share (Quarterly) | 7.317 |
| Free Cash Flow to Equity (Quarterly) | 346.10M |
| Free Cash Flow to Firm (Quarterly) | 348.42M |
| Free Cash Flow Yield | 4.75% |